
Samir Kapadia
Articles
-
Apr 8, 2024 |
firstpost.com | Samir Kapadia
In an era marked by rapid geopolitical shifts and economic uncertainty, Indian exporters find themselves navigating a complex global landscape. There are indeed challenges and opportunities that these fluctuations present to Indian businesses aiming to make their mark on the world stage. The current global environment is characterised by volatility. Trade wars, shifting alliances and the ongoing impacts of the COVID-19 pandemic have all played a part in creating an unpredictable market.
-
Nov 27, 2023 |
jacc.org | Megan Coylewright |David Holmes |Samir Kapadia |Jonathan Hsu
1. "Prevalence of extra-appendage thrombosis in non-valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: a large transoesophageal echo study". EuroIntervention . 2019;15:3: e225-e230. https://doi.org/10.4244/EIJ-D-19-00128. 2. "Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century". Int J Cardiol . 2013;167:5: 1807-1824. https://doi.org/10.1016/j.ijcard.2012.12.093. 3.
-
Nov 10, 2023 |
firstpost.com | Samir Kapadia
In an increasingly interconnected global economy, Indian businesses are leveraging the power of B2B marketplaces to expand their reach and tap into international sourcing opportunities. With the digital revolution, the traditional boundaries of trade have blurred, allowing Indian companies to access a vast array of global suppliers and customers.
-
Nov 2, 2023 |
icrjournal.com | Joost Daemen |Robert W. Yeh |Samir Kapadia |Mirvat Alasnag
Video Published: Views: 50 Likes: 0 Average (ratings) TCT 23 - We are joined by Dr Kendra Grubb (Emory School of Medicine, Atlanta, GA, US) for a concise and insightful summary of the late-breaking trials that are expected to have an impact on interventional science concerning structural heart disease and clinical practice. Trials covered in detail include:PARTNER 3 & EVOLUT Low-RiskALIGN-ARTENDYNEAPOLLOTRILUMINATERecorded remotely from Georgia, 2023.
-
Oct 24, 2023 |
healio.com | Katie Kalvaitis |Erik Swain |Samir Kapadia
You've successfully added Cardiac Vascular Intervention: Structural to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Atrial fibrillation is associated with increased risk for bleeding and stroke in patients undergoing TAVR.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →